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Abstract Femoral arterial thrombosis (FAT) is a non-
negligible complication after cardiac catheterization (CC)
in infancy. The aim of this study was to evaluate the impact
of Doppler ultrasound (US) for diagnostic work-up after
catheterization. We compared standard follow-up (FU)
without Doppler US by relying on clinical signs of FAT
with advanced FU using Doppler US of the femoral ves-
sels. Between January and December 2009, we evaluated
the rate of FAT in infants \12 months of age using a
multicenter, prospective observational survey. We analysed
171 patients [mean age 4.1 ± 3.3 (SD) months; mean body
weight 5.3 ± 1.8 kg] from 6 participating centres. The
mean duration of catheter studies was 57.7 ± 38.0 min.
The overall rate of FAT based on clinical diagnosis was
4.7 % and was comparable in both groups [3.4 % under-
going standard FU vs. 7.4 % undergoing advanced FU
(p = 0.15)]. However, the overall rate of thrombosis as
screened by Doppler US was greater at 7.1 %, especially in
patients after advanced FU [18.5 % advanced vs. standard
FU 1.7 % (p \ 0.01)]. In conclusion, FAT remains a rel-
evant and underestimated complication after catheteriza-
tion in young infants when relying only on clinical signs of
FAT. Therefore, to start effective treatment as soon as
possible, we recommend Doppler US to be performed the
day after CC.
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Complication  Arterial thrombosis
Introduction
The most frequent and relevant complications after cardiac
catheterization (CC) using femoral vascular access in early
childhood are arterial and venous thrombosis [11, 12, 20].
Femoral artery thrombosis (FAT) has been reported to occur
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in 8–39 % of young infants [7, 8, 19]. Premature babies with
birth weight \1,500 g, term newborns, and young infants
\1 year of age are at particular risk of thrombosis among the
pediatric population [2, 16]. Cardiac disease has been
reported to be a risk factor for thrombosis in childhood [1].
Patency of vascular access is mandatory in children under-
going subsequent procedures during their lifetime.
The estimated number of unknown cases of asymp-
tomatic forms of FAT in pediatric patients is probably
high, and these cases are often missed due to the immediate
recruitment of the collateral femoral artery vessels. Nev-
ertheless, during long-term FU, FAT may lead to com-
promised arterial supply of the distal leg with claudicatio
intermittens and significant leg length discrepancies at later
age. Postthrombotic syndrome may occur in cases of
femoral venous thrombosis [18]. FAT can be diagnosed
clinically with apparent different findings at the lower
extremities, including skin colour and temperature, capil-
lary refilling time, blood pressure, and palpable pulse.
Nevertheless, the clinical presentation of FAT in infancy
may be subtle, and therefore the diagnosis of FAT can be
missed. Doppler ultrasound (US) of the femoral artery,
including Doppler flow pattern and colour Doppler
modality, may detect partial or complete obstruction of the
femoral artery even in clinically inconspicuous cases. The
aim of the study was to determine the impact of Doppler
US as an additional diagnostic tool in making the diagnosis
of FAT after CC in infants.
Methods
Study Design
The study was planned and designed as a prospective,
multicenter, clinical observational survey to evaluate the
rate of FAT in infants\1 year of age after CC. The survey
was performed on behalf of the Working Group Interven-
tional Cardiology of the German Association of Pediatric
Cardiology. During 1 year, all consecutive patients were
included undergoing CC for diagnostic purposes or thera-
peutic interventions.
The primary end point of the trial was the rate of FAT on
the day after CC as documented by clinical diagnosis. Cri-
teria of clinical diagnosis of FAT were defined as cold and
pale lower extremities with decreased or absent palpable
pedal pulses and low blood pressure (systolic blood pressure
difference[20 mmHg between both legs). The second end
point was the rate of FAT as determined by Doppler US,
which was primarily based on obstructed pulsatile flow
pattern on Doppler US and colour Doppler using a linear
12-MHz transducer on high-end US equipment. Further-
more, we analysed risk factors contributing to FAT.
To analyse the impact of Doppler US on the diagnosis of
FAT, we defined two study groups: (1) the group called
standard FU included all patients whose diagnosis of FAT
was made clinically and secondarily confirmed by Doppler
US; and (2) the called advanced FU included those patients
who underwent Doppler US as a routine procedure the day
after CC independent of clinical signs of FAT.
All data were collected by a questionnaire, which was
sent to participating centres performing pediatric CC,
including therapeutic interventions, in Switzerland and
Germany. The following data were analysed: age; sex;
weight; length; cardiac diagnosis; cyanosis [defined as
transcutaneous oxygen saturation (tcSO2) with moderate
(80–90 %) and severe cyanosis (\80 %)]; anticoagulation
before and after CC; congestive heart failure (defined as
need for inotropics, such as adrenaline); haemoglobin;
hematocrit; and femoral artery puncture before CC. Addi-
tional periprocedural data including cumulative frequency
of vessel puncture, type and size of sheath used, need for
sheath exchange during CC, procedure time, pedal pulses
palpable before leaving CC laboratory, and mode of anti-
coagulation during CC were analysed. Postprocedural data
included clinical signs of FAT during the first 24 h after
CC according to our previously described criteria. FAT
determined by Doppler US was defined as an abnormal
obstructed flow pattern with partial or complete arterial
obstruction on Doppler and colour Doppler.
Doppler US was performed the day after CC after pressure
dressings were removed. Doppler US was performed by an
experienced pediatric radiologist using a 12-MHz linear US
probe in vascular mode and included two-dimensional col-
our and pulsed-wave Doppler flow. Ethical approval for the
study and data collection was obtained according to the
guidelines of the local ethics committees.
Statistics
For descriptive statistics, values are shown as mean ± SD.
Statistical comparison between the patients of the two defined
study groups, standard FU and advanced FU, was performed
using Mann–Whitney test for comparison of metric data, and
Chi-square test was used for comparison of frequencies;
p \ 0.05 was considered statistically significant.
Results
Patients
Between January and December 2009, the survey identified
249 consecutive patients from 6 participating centres in
Germany and Switzerland. Data sets of femoral arterial
access were available for 171 patients (92 female) for
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statistical analysis. CC was performed at (mean ± SD) a
patient age of 4.1 ± 3.3 months and a body weight of
5.3 ± 1.8 kg; the procedure time was 57.7 ± 38.0 min.
Cardiac diagnoses were acyanotic congenital heart disease
(tcSO2 [ 90 %) in 61.8 % and cyanotic congenital heart
disease (tcSO2 B90 %) in 39.2 % of patients, with 23.4 %
of patients having moderate (tcSO2 80–90 %) and 15.8 %
having severe cyanosis (tcSO2 B80 %). A minority of
patients (11.9 %) undergoing CC were treated for con-
gestive heart failure.
Complications
On the day after CC, 18 of 171 patients (10.5 %) had
clinical complications or pathologic findings on Doppler
US. Clinical complications included signs of arterial
thrombosis in 8 (4.7 %) and groin hematoma in 5 (2.9 %)
patients. Pathologic findings on Doppler US occurred in 12
patients (7.1 %), including complete in 9 and partial arte-
rial thrombosis in 3 patients.
Femoral Artery Thrombosis
Therefore, the overall rate of FAT made by clinical diag-
nosis was 4.7 %. Rates of FAT were comparable (p = 0.15)
in both study groups: 3.4 % of patients with standard FU
(clinical diagnosis) compared with 7.4 % in patients with
advanced FU (including additional Doppler US).
The overall rate of FAT detected by Doppler US
screening was greater at 7.1 % [18.5 % in patients with
advanced FU vs. 1.7 % in patients with clinical FU
(p \ 0.01)]. Table 1 lists different parameters of the two
FU modalities. Table 2 lists the patients with a complicated
course after CC and gives a detailed overview and rela-
tionship to different risk factors for FAT.
Vascular Access
Regarding the modalities of femoral artery puncture, the
majority of patients (71.4 %) had not been punctured before
CC. However, femoral artery access had been established
before CC at least one time in 23.1 % of patients and more
than one time in 5.5 % of patients, including preceding CC or
arterial lines placed during intensive care treatment.
The right femoral artery was preferred (82.5 %) for
vascular access compared with the left femoral artery
(10.5 %) and both arteries (7 %). Only one successful
puncture was needed in 62.2 % of patients; two to five
attempts were needed in 34.5 % of patients; and more than
five attempts were needed in 3.3 % of patients. Exchange
of the arterial sheath during CC was necessary in 7 % of
patients.
Anticoagulation
Anticoagulation before CC [including acetylsalicylic acid
(18.9 %) and heparin (7.5 %)] was given in 26.4 % of all
patients, but no patient was placed under phenprocoumon
medication (0 %). Anticoagulation during CC was per-
formed in 83.6 % of patients using heparin (intravenous
dose 100 IU/kg after puncture) and after CC at least for the
first 24 h in 86 % of patients using heparin or low
molecular weight heparin in therapeutic dosages. One
patient was treated with thrombolytic therapy after CC and
was excluded from further analysis.
Table 1 Comparison of infants (\12 months) undergoing CC with standard FU (clinical signs, differences of pulse, blood pressure by Doppler
US) with those undergoing advanced FU (including additional Doppler US) screening for FAT
Characteristics All (n = 171) Standard FU (n = 117) Advanced FU (n = 54) p
Age (months) 4.1 ± 3.3 4.0 ± 3.3 4.4 ± 3.4 0.42
Body weight (kg) 5.3 ± 1.8 5.3 ± 1.9 5.2 ± 1.6 0.72
Body length (cm) 59.3 ± 8.4 59.5 ± 8.3 58.8 ± 8.5 0.53
Arterial sheath size (F) 4.01 ± 0.25 4.05 ± 0.26 3.94 ± 0.23 0.14
Study time (min) 57.7 ± 38.0 55.6 ± 40.9 60.2 ± 34.6 0.20
Hemoglobin (g/dl) 13.4 ± 2.4 13.5 ± 2.8 13.3 ± 2.4 0.52
Hematocrit 40.4 ± 8.0 40.5 ± 7.8 40.3 ± 8.3 0.67
Cyanosis (tcSO2 \90 %) (%) 39.2 35.9 46.3 0.34
Anticoagulation during CC (%) 83.6 83.8 92.6 0.62
Anticoagulation after CC (%) 86.0 84.6 88.8 0.53
No. (%) with clinical signs of thrombosis 8 (4.7) 4 (3.4) 4 (7.4) 0.15
No. (%) with thrombosis by Doppler US 12 (7.1) 2 (1.7) 10 (18.5) 0.01
Data are given as mean ± SD. For statistical analysis, Mann–Whitney test was used for comparison of metric data, and v2 test was used for
comparison of frequencies
532 Pediatr Cardiol (2013) 34:530–535
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Discussion
The etiology of arterial thrombosis in childhood in most
cases is secondary to vessel trauma, e.g., arterial catheter-
ization, vessel sheaths, or arterial monitoring lines, whereas
primary noncatheter related arterial thrombosis is rare [14].
Therefore, the most frequent type of catheter-related arte-
rial thrombosis after CC requires peripheral and umbilical
artery catheterization [14]. The frequency of catheter-
related arterial thrombosis has increased due to the sub-
stantial progress made in pediatric intensive care, thus
enabling better survival rates of patients with life-threat-
ening diseases [9].
The main findings of this survey were that the clinical
diagnosis of FAT occurring after CC in infancy was made
in 4.7 % of all cases (3.4–7.4 %), whereas the rate of
diagnosis made by routine Doppler US was exceedingly
greater at 18.5 % (Table 1).
The clinical diagnosis of FAT on the first day after CC
was made using the previously mentioned criteria. Using
oscillometric blood pressure measurement, even when
optimized by additional hand-held Doppler pencil exami-
nation, the blood pressure difference between legs may be
difficult to detect due to movement artefacts of small,
restless infants. Therefore, colour Doppler US has become
a useful noninvasive diagnostic tool for diagnosing FAT,
although similar limitations of patient agitation during the
examination must be taken into account. Performed by
experienced hands, Doppler US allows a reliable diagnosis
or exclusion of FAT even in small children.
The rate of FAT in our survey is comparable with the
results of published studies of the last few decades [5–8,
15, 19]. Our data confirm the risk profile for FAT in small
children regarding rheology, including cyanosis, polycy-
themia, and congestive heart failure with low cardiac out-
put; technical aspects, such as previous vessel puncture,
sheath size, and sheath change; and prophylactic factors,
including anticoagulation during and after CC (Table 2).
Specific thrombolytic medical therapy was believed to be
necessary only in one patient, in whom it was successful
and without adverse events, as described in the literature
[3].
Although the overall incidence of thrombosis in child-
hood is very low (0.07/10.000) [2], risk populations include
young infants (\12 months) with congenital heart disease
undergoing CC and cardiac surgery requiring need for a
femoral arterial line [1, 2, 10, 13].
The total number of asymptomatic forms of FAT seems
to be underestimated. Although the predictive value of
pediatric thrombosis diagnosis in a Danish National Patient
Registry has been recently described as being rather low
(53.7 %), more detailed FU, including routine Doppler US
the day after CC, is recommended, [17]. Early diagnosis of
FAT is mandatory to avoid impaired limb growth and to
establish life-long patency of arterial vessel access.
Limitations of the study include primarily technical
factors regarding the clinical diagnosis of FAT, such as
difficulties in blood pressure measurements due to move-
ment artefacts as well as appropriate settings for Doppler
US in small, restless infants to reach optimal imaging
quality. Furthermore, we could not standardise the punc-
ture techniques, type of sheaths used, and characteristics of
bleeding control after CC, including the amount and type
of pressure dressing, due to the local differences among the
participating centres.
Conclusion
In conclusion, the rate of FAT in young infants after CC
may be underestimated due to missed clinical signs.
Therefore, the use of Doppler US is recommended in those
cases in which FAT may be suspected. Future studies must
determine the medium-term outcome of FAT, which was
not part of this survey. A recent study has shown impres-
sive efficacy of enoxaparin for the management of FAT in
children after CC: for indwelling catheters during medium-
term FU, the vessel patency rate was 91 % after 1 month
[4]. These results emphasize that a timely diagnosis of FAT
is mandatory for the early initiation of anticoagulatory
therapy, which can result in excellent vessel-reopening
rates in this patient group.
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